HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Targets Premium, “Super-Premium” Segments For U.S. Growth

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive looks to capture U.S. oral-care share with high-end innovations in the mouthwash and toothbrush categories. A the Barclays Americas Select Franchise Conference, Colgate president North America and global sustainability says the firm expects to build awareness quickly for Colgate Total Pro-Shield mouthwash, while preparing to launch a toothbrush that makes brushing “exciting.”

You may also be interested in...



Colgate Total Mouthwash Debut Makes “Complete Regimen”

Colgate-Palmolive rounds out its Colgate Total line with Pro-Shield mouthwash, bowing in the firm’s second quarter. Firm plans to support the launch with a “very robust” integrated marketing campaign featuring talk-show host Kelly Ripa.

Colgate Sensitivity, Whitening Pastes Lead “Robust” Q1 Pipeline

Colgate-Palmolive will launch Colgate Total Zx Pro-Shield Plus Sensitivity toothpaste and Colgate Optic White Dual Action toothpaste in the U.S. in the first quarter, the firm announced in a Jan. 31 earnings call. Colgate’s net sales in North America rose 3.4% in fiscal 2012 to $3.1 billion.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel